Konrad K.
- Country
- Germany
- Department
- Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie
Research Overview
- Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Ficlatuzumab and Cetuximab in Recurrent or Metastatic HPV-Negative Head and Neck Squamous Cell Carcinoma
- Evaluation of Petosemtamab Versus Investigator's Choice Monotherapy in Previously Treated Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma
Data & Insights
Has run more than one trial at 97 of 253 partner sites.
Specializations
Hematologic Malignancies
Konrad Klinghammer is involved in clinical research across acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, multiple myeloma, and a broad range of lymphomas, including diffuse large B-cell lymphoma, mantle cell lymphoma, and Hodgkin lymphoma.
- Leukemia
- Lymphoma
- Multiple myeloma
- Myelodysplastic syndromes
His trial portfolio also includes advanced cellular and antibody-based approaches in relapsed and refractory hematologic disease.
Solid Tumors and Precision Oncology
His clinical research landscape includes non-small cell lung cancer, breast cancer, colorectal cancer, gastric cancer, ovarian cancer, melanoma, hepatocellular carcinoma, and urothelial carcinoma, with strong activity in biomarker-defined and molecularly targeted oncology.
- Non-small cell lung cancer
- Breast cancer
- Colorectal cancer
- Melanoma
He is also engaged in studies addressing HER2, KRAS, EGFR, RET, and BRAF-driven malignancies.
Autoimmune and Inflammatory Diseases
Konrad Klinghammer is active in trials for systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease, and systemic sclerosis, reflecting a strong therapeutic focus on chronic immune-mediated disorders.
- Systemic lupus erythematosus
- Inflammatory bowel disease
- Psoriatic disease
- Vasculitis
His work also extends to atopic dermatitis, hidradenitis suppurativa, urticaria, and myositis.
Transplantation and Renal Medicine
His research includes kidney transplantation, transplant rejection, antibody-mediated rejection, chronic kidney disease, IgA nephropathy, focal segmental glomerulosclerosis, and Alport syndrome, alongside other renal and immune-mediated kidney disorders.
- Kidney transplantation
- Chronic kidney disease
- IgA nephropathy
- Proteinuric glomerular disease
He is also involved in studies of renal allograft protection and post-transplant immune complications.
Cardiometabolic, Neurologic, and Rare Diseases
Konrad Klinghammer’s trial activity further spans cardiovascular disease, heart failure, atrial fibrillation, myocardial infarction, stroke, migraine, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease, as well as selected rare diseases such as amyloidosis, mastocytosis, and hereditary angioedema.
- Cardiovascular disease
- Neurodegenerative disease
- Demyelinating disease
- Rare systemic disorders
His portfolio also includes therapeutic studies in metabolic liver disease and obesity-related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.